ClinicalTrials.govpublic full text
Targeting Triple Negative BREAst Cancer Metabolism With a Combination of Chemoimmunotherapy and a FASTing-like Approach in the Preoperative Setting: the BREAKFAST 2 Trial
breast cancer, triple negative breast cancer, dietary exposure, fasting
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 253006
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.